Characterization of the population with severe iron deficiency anemia at risk of requiring intravenous iron supplementation

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 224, Issue , 2018, Pages 41-44

  Estadella, Josep ^a   Villamarín, Laura ^a   Feliu, Anna ^a   Perelló, Josep ^a   Calaf, Joaquim ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Heavy menstrual bleeding; Iron deficiency anemia; Iron supplementation; Pregnancy

Indexed keywords

IRON; TRACE ELEMENT;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHILD; FEMALE; HUMAN; INFANT; IRON DEFICIENCY ANEMIA; IRON THERAPY; MAJOR CLINICAL STUDY; MALE; MATERNAL AGE; MENORRHAGIA; OBSTETRIC HEMORRHAGE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; VERY ELDERLY; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; PRESCHOOL CHILD; SPAIN; YOUNG ADULT;

ADMINISTRATION, INTRAVENOUS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA, IRON-DEFICIENCY; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; IRON; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SPAIN; TRACE ELEMENTS; YOUNG ADULT;

EID: 85043363346     PISSN: 03012115     EISSN: 18727654     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2018.03.005     Document Type: Article

References (19)

1. Salud OMDL. Worldwide prevalence of anaemia 1993-2005. WHO Global Database on Anaemia. http://whqlibdoc.who.int/publications/2008/9789241596657_eng.pdf. (Accesed Mayo 2016).
2. Perez, G., Vittori, D., Pregi, N., Garbossa, G., Homeostasis del hierro Mecanismos de absorción, captación celular y regulación. Acta. Bioquím. Clín. Latinoam. 39 (2005), 301–314.
3. Guralnik, J.M., Eisenstaedt, R.S., Ferrucci, L., Klein, H.G., Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood 104 (2004), 2263–2268.
4. Bilbao, J., Anemias carenciales I: anemia ferropénica. Información terapéutica del Sistema Nacional de Salud. 30 (2006), 35–40.
5. Moreno, J.A., Romero, M.S., Gutiérrez, M., Classification of anemia for gastroenterologists. World J. Gastroenterol. 15 (2009), 4627–4637.
6. Lopez, A., Cacoub, P., MacDougall, I.C., Peyrin-Biroulet, L., Iron deficiency anaemia. Lancet(15), 2015, S0140–S6736 60865.
7. Camaschella, C., Iron-deficiency anemia. N. Engl. J. Med. 372 (2015), 1832–1843.
8. Garcia-Erce, J.A., Fernandez-Perez, C., Rubio, D., Balance riesgo-beneficio de los agentes eritropoyéticos frente a la transfusión. Anemia 2 (2009), 136–142.
9. Madrazo-Gonzalez, Z., Garcia-Barrasa, A., Hierro intravenoso. Cir. Esp. 86 (2009), 196–203.
10. Bisbe Vives, E., Basora Macaya, M., Algorithm for treating preoperative anemia. Rev. Esp. Anestesiol. Reanim. 62:Suppl. (1) (2015), 27–34.
11. P C. Intravenous Versus Oral Iron in Late Pregnancy: Results of Treatment (EIVF). NCT00746551.
12. Palacios, S., The management of iron deficiency in menometrorrhagia. Gynecol Endocrinol. 27 (2011), 1126–1130.
13. Marret, H., Fauconnier, A., Chabbert-Buffet, L., Cravello, L., Clinical practice guidelines on menorrhagia: management of abnormal uterine bleeding before manopause. Eur. J. Obstet. Gynecol. Reprod. Biol., 2010.
14. Munro, M.G., Critchley, H.O.D., Broder, M.S., Fraser, I.S., FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int. J. Gynecol. Obst. 113 (2011), 3–13.
15. Mayson, E., ntravenous iron: barriers and facilitators to its use at nine maternity hospitals in New South Wales, Australia. Aust. N. Z. J. Obstet. Gynaecol. 56 (2015), 162–172.
16. Onken, J.E., Bregman, D.B., Harrington, R.A., A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia. Transfusion (Paris) 54 (2014), 306–315.
17. Vadhan-Raj, S., Strauss, W., Ford, D., Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral iron. Am. J. Hematol. 9 (2014), 7–12.
18. Bager, P., Dahlerup, J.F., The health care cost of intravenous iron treatment in IBD patients depends on the economic evaluation perspective. J. Crohns. Colitis 4 (2010), 427–430.
19. Cataluña. ADSPDCGD. Indicadores de salud perinatal en Cataluña. Año 2013. http://salutpublicagencatcat/ca/vigilancia_salut_publica/monitoratge_perinatal/ (Accesed Mayo 2016).